Stock 300406 BEIJING STRONG BIOTECHNOLOGIES,INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Beijing Strong Biotechnologies,Inc.

Equities

300406

CNE100001Y26

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
18.53 CNY +0.22% Intraday chart for Beijing Strong Biotechnologies,Inc. +6.13% -2.98%
04-28 Beijing Strong Biotechnologies,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-25 Beijing Strong Biotechnologies,Inc. Announces Final Cash Dividend (Tax Included) (A Shares) for 2023, Payable on 07 May 2024 CI

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 8,159 14,737 11,674 9,611 11,206 10,862 - -
Enterprise Value (EV) 1 8,159 14,737 11,674 9,611 11,206 10,862 10,862 10,862
P/E ratio 24.6 x 119 x 28.7 x 24.4 x 21.7 x 17.6 x 14.1 x 11.7 x
Yield - - - 0.61% - 1.3% 1.57% 1.89%
Capitalization / Revenue 9.7 x 17.4 x 7.3 x 6.36 x 6.43 x 5.29 x 4.47 x 3.78 x
EV / Revenue 9.7 x 17.4 x 7.3 x 6.36 x 6.43 x 5.29 x 4.47 x 3.78 x
EV / EBITDA - 79,754,215 x - 13,523,933 x - - - -
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - 4.61 x 4.06 x 3.12 x 3.02 x 2.58 x 2.24 x 1.93 x
Nbr of stocks (in thousands) 501,788 588,997 588,984 587,124 586,727 586,193 - -
Reference price 2 16.26 25.02 19.82 16.37 19.10 18.53 18.53 18.53
Announcement Date 28/02/20 25/03/21 26/04/22 19/04/23 29/03/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 840.9 848.1 1,599 1,511 1,742 2,052 2,429 2,876
EBITDA - 184.8 - 710.7 - - - -
EBIT 1 - 153 535.9 455.5 593.9 709 874.5 1,066
Operating Margin - 18.05% 33.5% 30.15% 34.1% 34.55% 36% 37.05%
Earnings before Tax (EBT) 1 - 136.9 537 449.4 593.6 709 874 1,066
Net income 1 - 112.3 405.7 389.1 523.7 618.5 769.5 938
Net margin - 13.24% 25.36% 25.76% 30.07% 30.14% 31.68% 32.61%
EPS 2 0.6600 0.2100 0.6900 0.6700 0.8800 1.050 1.310 1.590
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - 0.1000 - 0.2400 0.2900 0.3500
Announcement Date 28/02/20 25/03/21 26/04/22 19/04/23 29/03/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - 4.46% 12.1% 12.7% 14.9% 15% 16.2% 16.9%
ROA (Net income/ Total Assets) - - - 8.71% - 10.3% 10.9% 11.5%
Assets 1 - - - 4,466 - 6,005 7,060 8,157
Book Value Per Share 2 - 5.430 4.880 5.250 6.330 7.180 8.270 9.620
Cash Flow per Share 2 - 0.2100 0.5800 0.6700 0.9900 0.6700 1.140 1.340
Capex 1 - 16.9 65 96.5 147 126 136 151
Capex / Sales - 1.99% 4.06% 6.39% 8.44% 6.14% 5.6% 5.25%
Announcement Date 28/02/20 25/03/21 26/04/22 19/04/23 29/03/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Beijing Strong Biotechnologies,Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
18.53
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Diagnostic & Testing Substances

1st Jan change Capi.
BEIJING STRONG BIOTECHNOLOGIES,INC. Stock Beijing Strong Biotechnologies,Inc.
-2.98% 1.5B
BIOMÉRIEUX Stock bioMérieux
-1.89% 12.5B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. Stock Shenzhen New Industries Biomedical Engineering Co., Ltd.
-9.59% 7.67B
LANTHEUS HOLDINGS, INC. Stock Lantheus Holdings, Inc.
+21.82% 5.36B
DIASORIN S.P.A. Stock DiaSorin S.p.A.
-1.31% 5.26B
AUTOBIO DIAGNOSTICS CO., LTD. Stock Autobio Diagnostics Co., Ltd.
+0.02% 4.57B
10X GENOMICS, INC. Stock 10x Genomics, Inc.
-50.89% 3.15B
ANDON HEALTH CO., LTD. Stock Andon Health Co., Ltd.
+6.42% 2.59B
VITROLIFE AB Stock Vitrolife AB
-10.02% 2.06B
GUANGZHOU WONDFO BIOTECH CO.,LTD Stock Guangzhou Wondfo Biotech Co.,Ltd
-8.29% 1.79B
Diagnostic & Testing Substances
  1. Stock Market
  2. Equities
  3. 300406 Stock
  4. Financials Beijing Strong Biotechnologies,Inc.